LightOx Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
17
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$117K
- Investors
-
12
LightOx General Information
Description
Developer of light-activated therapeutics and technology designed to improve patients' function and long-term outcomes. The company offers light-activated therapies targeting oral pre-cancer, antimicrobial applications, and a light-activated spray for wound care, enabling patients, healthcare providers, and emergency medical teams, enabling treatment of oral disease, infections, and traumatic injuries.
Contact Information
Website
www.lightox.co.ukCorporate Office
- 65 Westgate Road
- Newcastle upon Tyne NE1 1SG
- England, United Kingdom
Corporate Office
- 65 Westgate Road
- Newcastle upon Tyne NE1 1SG
- England, United Kingdom
LightOx Timeline
LightOx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Accelerator/Incubator | 01-Jan-2026 | $117K | Completed | Pre-Clinical Trials | ||
| 11. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 10. Later Stage VC (Series A) | 03-May-2024 | Completed | Pre-Clinical Trials | |||
| 9. Grant | 06-Jun-2023 | Completed | Pre-Clinical Trials | |||
| 8. Grant | 01-Jan-2022 | Completed | Pre-Clinical Trials | |||
| 7. Seed Round | 12-Oct-2021 | Completed | Pre-Clinical Trials | |||
| 6. Grant | 01-Jun-2020 | Completed | Pre-Clinical Trials | |||
| 5. Grant | 01-Dec-2019 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 02-May-2019 | $467K | $467K | Completed | Pre-Clinical Trials | |
| 3. Angel (individual) | 01-Jan-2018 | Completed | Pre-Clinical Trials |
LightOx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| A1 Ordinary | ||||||||
| A1 Ordinary | ||||||||
| Ordinary | 288 | $0.125071 | $254.1 | $254.1 | 1x | $254.1 | 0.67% | |
| Ordinary | 3,655 | $0.125071 | $122.65 | $122.65 | 1x | $122.65 | 8.5% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
LightOx Comparisons
Industry
Financing
Details
LightOx Competitors (4)
One of LightOx’s 4 competitors is ImPact Biotech, a Corporation company based in Ness Ziona, Israel.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ImPact Biotech | Corporation | Ness Ziona, Israel | ||||
| Aura Biosciences | Formerly VC-backed | Boston, MA | ||||
| Rakuten Medical | Venture Capital-Backed | San Diego, CA | ||||
| Photocure | Corporate Backed or Acquired | Oslo, Norway |
LightOx Patents
LightOx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202313555-D0 | Compositions and methods for the treatment and prevention of bacterial infections casued by gram-positive bacteria | Inactive | 05-Sep-2023 | ||
| AU-2024337829-A1 | Compositions and methods for the treatment and prevention of bacterial infections caused by gram-positive bacteria | Pending | 05-Sep-2023 | ||
| EP-4773964-A1 | Compositions and methods for the treatment and prevention of bacterial infections caused by gram-positive bacteria | Pending | 05-Sep-2023 | ||
| JP-2026530107-A | Compositions and methods for the treatment and prevention of bacterial infections caused by gram-positive bacteria | Pending | 05-Sep-2023 | ||
| WO-2025051640-A1 | Compositions and methods for the treatment and prevention of bacterial infections caused by gram-positive bacteria | Inactive | 05-Sep-2023 | A61K31/496 |
LightOx Signals
LightOx Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Diana (UK) | Accelerator/Incubator | Minority | ||
| Pxn Ventures | Corporate Venture Capital | Minority | ||
| NG Bio (UK) | Venture Capital | Minority | ||
| Northstar Ventures | Venture Capital | Minority | ||
| Innovate UK | Government |
LightOx FAQs
-
When was LightOx founded?
LightOx was founded in 2016.
-
Where is LightOx headquartered?
LightOx is headquartered in Newcastle upon Tyne, United Kingdom.
-
What is the size of LightOx?
LightOx has 17 total employees.
-
What industry is LightOx in?
LightOx’s primary industry is Drug Discovery.
-
Is LightOx a private or public company?
LightOx is a Private company.
-
What is LightOx’s current revenue?
The current revenue for LightOx is .
-
How much funding has LightOx raised over time?
LightOx has raised $4.62M.
-
Who are LightOx’s investors?
Diana (UK), Pxn Ventures, NG Bio (UK), Northstar Ventures, and Innovate UK are 5 of 12 investors who have invested in LightOx.
-
Who are LightOx’s competitors?
ImPact Biotech, Aura Biosciences, Rakuten Medical, and Photocure are competitors of LightOx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process